Moreover, the high transcript level of selected SASP factors (IL6, IL1b, CXCL1, TNF-α) in cancerous tissues suggests their role in HNSCC development which could point future targeting of senescent cells as a secondary treatment might be beneficial for HNSCC patients. This evidence concerns the gene TNF and head and neck squamous cell carcinoma.